Page last updated: 2024-08-22

tricalcium phosphate and foscarnet

tricalcium phosphate has been researched along with foscarnet in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sallis, JD; Williams, G1
Loghman-Adham, M1
Sorribas, V; Villa-Bellosta, R1
Fullerton, DA; Lee, JH; Meng, X; Nadlonek, NA; Weyant, MJ1

Reviews

1 review(s) available for tricalcium phosphate and foscarnet

ArticleYear
Use of phosphonocarboxylic acids as inhibitors of sodium-phosphate cotransport.
    General pharmacology, 1996, Volume: 27, Issue:2

    Topics: Animals; Antiviral Agents; Biological Transport; Calcium Phosphates; Carrier Proteins; Digestive System; Foscarnet; Intestinal Absorption; Kidney; Phosphates; Sodium-Phosphate Cotransporter Proteins; Symporters

1996

Other Studies

3 other study(ies) available for tricalcium phosphate and foscarnet

ArticleYear
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
    Calcified tissue international, 1982, Volume: 34, Issue:2

    Topics: Adenosine Triphosphate; Calcium Phosphates; Citrates; Citric Acid; Durapatite; Etidronic Acid; Foscarnet; Glyceric Acids; Hydroxyapatites; Lasers; Magnesium; Nephelometry and Turbidimetry; Phosphates; Phosphonoacetic Acid; Structure-Activity Relationship

1982
Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition.
    Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:5

    Topics: Animals; Calcinosis; Calcium Phosphates; Cells, Cultured; Foscarnet; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphate Transport Proteins; Rats; Reverse Transcriptase Inhibitors

2009
ox-LDL induces PiT-1 expression in human aortic valve interstitial cells.
    The Journal of surgical research, 2013, Volume: 184, Issue:1

    Topics: Adult; Aortic Valve; Aortic Valve Stenosis; Bone Morphogenetic Protein 2; Calcinosis; Calcium Phosphates; Cells, Cultured; Foscarnet; Humans; Lipoproteins, LDL; Male; Middle Aged; Prevalence; Risk Factors; Signal Transduction; Sodium-Phosphate Cotransporter Proteins, Type III

2013